Cynerio

Cynerio is a cybersecurity company focused on healthcare IoT and connected medical device security. The company was founded in 2018 and is headquartered in New York, with R&D operations in Israel. Cynerio raised a $30M Series B funding round in 2022.

Cynerio's primary product is a platform for discovering, monitoring, and securing connected medical devices and clinical IoT assets within hospital networks. The core problem it addresses is the visibility gap in healthcare environments, where clinical devices such as infusion pumps, imaging systems, and patient monitors are networked but often invisible to standard IT security tools, leaving them exposed to ransomware and other attacks. The buyers are hospital IT and security teams, and the company operates in the enterprise healthcare sector. The platform performs passive network traffic analysis to identify and classify devices without requiring agents installed on the devices themselves — a significant technical constraint in clinical environments where device availability is safety-critical.

Cynerio competes in the healthcare IoT security segment alongside companies such as Claroty, Medigate (acquired by Claroty in 2022), and Armis. The segment has seen consolidation, with Medigate's acquisition into Claroty being a notable marker of the competitive landscape Cynerio operates within.